Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Bacterial resistance to CRISPR-Cas antimicrobials
Ruben Vazquez-Uribe, Christin Rathmer, Leonie J. Jahn, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 44

Showing 1-25 of 44 citing articles:

Engineered phage with antibacterial CRISPR–Cas selectively reduce E. coli burden in mice
Yilmaz Emre Gençay, Džiuginta Jasinskytė, Camille Robert, et al.
Nature Biotechnology (2023) Vol. 42, Iss. 2, pp. 265-274
Open Access | Times Cited: 85
CRISPR-Cas-Based Antimicrobials: Design, Challenges, and Bacterial Mechanisms of Resistance
Arianna Mayorga-Ramos, Johana Zúñiga-Miranda, Saskya E. Carrera-Pacheco, et al.
ACS Infectious Diseases (2023) Vol. 9, Iss. 7, pp. 1283-1302
Open Access | Times Cited: 43
Type IV-A3 CRISPR-Cas systems drive inter-plasmid conflicts by acquiring spacers in trans
Fabienne Benz, Sarah Camara-Wilpert, Jakob Russel, et al.
Cell Host & Microbe (2024) Vol. 32, Iss. 6, pp. 875-886.e9
Closed Access | Times Cited: 14
The Application of the CRISPR-Cas System in Antibiotic Resistance
Shuan Tao, Huimin Chen, Na Li, et al.
Infection and Drug Resistance (2022) Vol. Volume 15, pp. 4155-4168
Open Access | Times Cited: 55
Exploring nano-enabled CRISPR-Cas-powered strategies for efficient diagnostics and treatment of infectious diseases
Ankit Kumar Dubey, Vijai Kumar Gupta, Małgorzata Kujawska, et al.
Journal of nanostructure in chemistry (2022) Vol. 12, Iss. 5, pp. 833-864
Open Access | Times Cited: 47
Intestinal colonization with multidrug-resistant Enterobacterales: screening, epidemiology, clinical impact, and strategies to decolonize carriers
Edgar I. Campos-Madueno, Melika Moradi, Yasmine Eddoubaji, et al.
European Journal of Clinical Microbiology & Infectious Diseases (2023) Vol. 42, Iss. 3, pp. 229-254
Open Access | Times Cited: 35
Associate toxin-antitoxin with CRISPR-Cas to kill multidrug-resistant pathogens
Rui Wang, Xian Shu, Huiwei Zhao, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 22
Recent Advances in Understanding the Molecular Mechanisms of Multidrug Resistance and Novel Approaches of CRISPR/Cas9-Based Genome-Editing to Combat This Health Emergency
Khaled S. Allemailem
International Journal of Nanomedicine (2024) Vol. Volume 19, pp. 1125-1143
Open Access | Times Cited: 11
Antimicrobial resistance (AMR) management using CRISPR-Cas based genome editing
Debmitra Sen, Poulami Mukhopadhyay
Gene and Genome Editing (2024) Vol. 7, pp. 100031-100031
Open Access | Times Cited: 8
Systematic interrogation of CRISPR antimicrobials in Klebsiella pneumoniae reveals nuclease-, guide- and strain-dependent features influencing antimicrobial activity
Elena Vialetto, Solange Miele, Moran G. Goren, et al.
Nucleic Acids Research (2024) Vol. 52, Iss. 10, pp. 6079-6091
Open Access | Times Cited: 6
Harnessing CRISPR interference to resensitize laboratory strains and clinical isolates to last resort antibiotics
Angelica Frusteri Chiacchiera, Michela Casanova, Massimo Bellato, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Developing a Versatile Arsenal: Novel Antimicrobials as Offensive Tools Against Pathogenic Bacteria
Junze Ma, Zheng Lu
Microorganisms (2025) Vol. 13, Iss. 1, pp. 172-172
Open Access
New Frontiers in CRISPR: Addressing Antimicrobial Resistance with Cas9, Cas12, Cas13, and Cas14
Ahmed S.A. Ali Agha, Ali Al‐Samydai, Talal Aburjai
Heliyon (2025) Vol. 11, Iss. 2, pp. e42013-e42013
Open Access
Biomaterials-mediated CRISPR/Cas9 delivery: recent challenges and opportunities in gene therapy
Ankit Kumar Dubey, Ebrahim Mostafavi
Frontiers in Chemistry (2023) Vol. 11
Open Access | Times Cited: 18
Role of CRISPR-Cas systems and anti-CRISPR proteins in bacterial antibiotic resistance
Hiva Kadkhoda, Pourya Gholizadeh, Hossein Samadi Kafil, et al.
Heliyon (2024) Vol. 10, Iss. 14, pp. e34692-e34692
Open Access | Times Cited: 4
Biocontainment strategies for in vivo applications of Saccharomyces boulardii
Karl Alex Hedin, Vibeke Kruse, Ruben Vazquez-Uribe, et al.
Frontiers in Bioengineering and Biotechnology (2023) Vol. 11
Open Access | Times Cited: 13
CRISPR-Cas System: A Tool to Eliminate Drug-Resistant Gram-Negative Bacteria
Rajeshwari Rajesh Kundar, Karuna Gokarn
Pharmaceuticals (2022) Vol. 15, Iss. 12, pp. 1498-1498
Open Access | Times Cited: 20
Improving the Editing Efficiency of CRISPR-Cas9 by Reducing the Generation of Escapers Based on the Surviving Mechanism
Qi Li, Mingjun Sun, Lu Lv, et al.
ACS Synthetic Biology (2023) Vol. 12, Iss. 3, pp. 672-680
Closed Access | Times Cited: 9
A comprehensive appraisal of mechanism of anti-CRISPR proteins: an advanced genome editor to amend the CRISPR gene editing
Nisha Choudhary, Dipty Tandi, Rakesh Kumar Verma, et al.
Frontiers in Plant Science (2023) Vol. 14
Open Access | Times Cited: 9
CRISPR-Based Gene Editing in Acinetobacter baumannii to Combat Antimicrobial Resistance
Muhammad Junaid, Krit Thirapanmethee, Piyatip Khuntayaporn, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 7, pp. 920-920
Open Access | Times Cited: 8
CRISPR Tools for Engineering Prokaryotic Systems: Recent Advances and New Applications
Diego Alba Burbano, Cholpisit Kiattisewee, Ava V. Karanjia, et al.
Annual Review of Chemical and Biomolecular Engineering (2024) Vol. 15, Iss. 1, pp. 389-430
Closed Access | Times Cited: 2
The CRISPR/Cas system as an antimicrobial resistance strategy in aquatic ecosystems
Sobin Sonu Gupta, Muneeb Hamza Kh, C.L. Sones, et al.
Functional & Integrative Genomics (2024) Vol. 24, Iss. 3
Closed Access | Times Cited: 2
Pathogen-Specific Bactericidal Method Mediated by Conjugative Delivery of CRISPR-Cas13a Targeting Bacterial Endogenous Transcripts
Zihao Song, Yue Yu, Xinpeng Bai, et al.
Microbiology Spectrum (2022) Vol. 10, Iss. 4
Open Access | Times Cited: 13
Intein-based thermoregulated meganucleases for containment of genetic material
Gary W. Foo, Christopher D. Leichthammer, Ibrahim M. Saita, et al.
Nucleic Acids Research (2024) Vol. 52, Iss. 4, pp. 2066-2077
Open Access | Times Cited: 1
Challenges and Emerging Molecular Approaches in Combating Antimicrobial Resistance
Gene Philip Levee Ynion, Christian Jay Rosal, Arvin Zulueta, et al.
Journal of Bacteriology and Virology (2024) Vol. 54, Iss. 1, pp. 12-39
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top